Diagnostic criteria for Parkinsons syndromes, expecting Parkinson's disease;Criteres diagnostiques des syndromes parkinsoniens en dehors de la maladie de Parkinson

Revue Neurologique

Volumn 156, Issue SUPPL. 2 BIS, 2000, Pages 43-50

  Vidailhet, M ^a,b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; CORTICOBASAL DEGENERATION; DEGENERATIVE DISEASE; DIFFERENTIAL DIAGNOSIS; DIFFUSE LEWY BODY DISEASE; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; ELECTROOCULOGRAPHY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PARKINSONISM; PROGRESSIVE SUPRANUCLEAR PALSY; SHY DRAGER SYNDROME; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

HUMANS; MULTIPLE SYSTEM ATROPHY; PARKINSON DISEASE; PARKINSONIAN DISORDERS; SUPRANUCLEAR PALSY, PROGRESSIVE;

EID: 0033942463     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (114)

1. ADAM AN, DO ORINDA. (1986). Focal paroxysmal kinesigenic choreoathetosis preceding the development of Steele Richardson olszewski syndrome. J Neurol Neurosurg Psychiatry, 49: 957-958.
2. ADAMS RD, VAN BOGAERT L, VAN DER EECKEN H. (1961). Dégénérescence nigro-striées et cérébello-nigro-striées. Psychiatria Neurologia. 142: 219-259.
3. ALBANESE A, COLOSIMO C, BENTIVOGLIO AR, FENICI R, MELILLO G, TONALI P. (1995). Multiple system atrophy presenting as parkinsonism: clinical features and diagnostic criteria. J Neurol Neurosurg Psychiatry, 59: 144-151.
4. BHATIA KP, LEE MS, RINNE JO, REVESZ T, SCARAVILLI F, DAVIES L, MARSDEN CD. (2000). Corticobasal degeneration look-alikes. Adv Neurol, 82: 169-182.
5. BARCLAY CL, LANG AE. (1997). Dystonia in progressive supranuclear palsy. J Neurol Neurosurg Psychiatry, 62: 352-356.
6. BARCLAY CL, BERGERON C, LANG AE. (1999). Arm levitation in progressive supranuclear palsy. Neurology, 52: 879-882.
7. BEN-SHLOMO Y, WENNING GK, TISON F, QUINN NP. (1997). Survival of patients with pathologically proven multiple system atrophy: a meta-analysis. Neurology, 48: 384-393.
8. BECK RO, BETTS CD, FOWLER CJ. (1994). Genitourinary dysfunction in multiple system atrophy: clinical features and treatment in 62 cases. J Urol, 151: 1336-1341.
9. BERGERON C, POLLANEN MS, WEYER L, BLACK SE, LANG AE. (1996). unusual clinical presentations of cortico-basal ganglionic degeneration. Ann Neurol, 40: 893-900.
10. BERGERON C, DAVIS A, LANG AE. (1998). Corticobasal ganglionic degeneration and progressive supranuclear palsy presenting with cognitive decline. Brain Pathol, 8: 355-365.
11. BLIN J, BARON JC, DUBOIS B, PILLON B, CAMBON H, CAMBIER J, AGID Y. (1990). Positron emission tomography study in progressive supranuclear palsy. Brain hypometabolic pattern and clinicometabolic correlations. Arch Neurol, 47: 747-752.
12. BIGIO EH, BROWN DF, WHITE CL. (1999). Progressive supranuclear palsy with dementia: cortical pathology. J Neuropathol Exp Neurol, 58: 359-364.
13. BLACK SE. (2000). Aphasia in Corticobasal degeneration. Adv Neurol, 82: 123-33.
14. BONNET AM, PICHON J, VIDAILHET M, GOUIDER-KHOUJA N, ROBAIN G, PERRIGOT M, AGIO Y. (1997). Urinary disturbances in striatonigral degeneration and Parkinson's disease: clinical and urodynamic aspects. Mov Disord, 12: 509-513.
15. BOWER JH, MARAGANORE DM, MCDONNELL SK, ROCCA WA. (1990). Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990. Neurology, 49: 1284-1288.
16. CARELLA F, SCAIOLI V, FRANCESCHETTI S, GIROTTI F, GIOVANNINI P, CIANO C, CARACENI T. (1991). Focal reflex myoclonus in corticobasal degeneration. Funct Neurol, 6: 165-170.
17. COLLINS SJ, AHLSKOG JE, PARISI JE, MARAGANORE DM. (1995). Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria. J Neurol Neurosurg Psychiatry, 58: 167-173.
18. COLOSIMO C, ROSSI P, ELIA M, BENTIVOGLIO AR, ALTAVISTA MC, ALBANESE A. (1991). Transient alternating hemichorea as presenting sign of progressive supranuclear palsy. Ital J Neurol Sci, 12: 99-101.
19. COLOSIMO C, ALBANESE A, HUGHES AJ, DE B, V, LEES AJ. (1995). Some specific clinical features differentiate multiple system atrophy (striatonigral variety) from Parkinson's disease. Arch Neurol, 52: 294-298.
20. COLOSIMO C. (1998). Pisa syndrome in a patient with multiple system atrophy. Mov Disord, 13: 607-609.
21. COSTA C, DUYCKAERTS C, CERVERA P, HAUW JJ. (1992). Les inclusions oligodendrogliales, un marqueur des atrophies multsystematisées. Rev Neurol (Paris), 148: 274-280.
22. DANIEL SE, DE B, V, LEES AJ. (1995). The clinical and pathological spectrum of Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy): a reappraisal. Brain, 118: 759-770.
23. DE B, V, MACHADO C, HOWARD RS, HIRSCH NP, LEES AJ. (1996). Nocturnal and respiratory disturbances in Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Postgrad Med J, 72: 293-296.
24. DE YEBENES JG, SARASA JL, DANIEL SE, LEES AJ. (1995). Familial progressive supranuclear palsy. Description of a pedigree and review of the literature. Brain, 118: 1095-1103.
25. DEFAZIO G, DE MARI M, DE SALVIA R, LAMBERTI P, GIORELLI M, LIVREA P. (1999). "Apraxia of eyelid opening" induced by levodopa therapy and apomorphine in atypical parkinsonism (possible progressive supranuclear palsy): a case report. Clin Neuropharmacol, 22: 292-294.
26. DÉJERINE J, THOMAS AA. (1890). L'atrophie olivo-ponto-cérébelleuse. Nouv Iconogr Salpêtrière, 13: 330-370.
27. DICKSON DW, LIN W, LIU WK, YEN SH. (1999). Multiple system atrophy: a sporadic synucleinopathy. Brain Pathol, 9: 721-732.
28. DUBAS F, VIDAILHET M, HENIN D. (1992). Confrontation anatomoclinique de la Salpetriere. Novembre 1990. Syndrome parkinsonien peu réactif à la dopathérapie chez un homme de 46 ans. Rev Neurol (Paris), 148: 580-585.
29. DUBOIS B, PILLON B, LEGAULT F, AGID Y, LHERMITTE F. (1988). Slowing of cognitive process in progressive supranuclear palsy: comparison with Parkinson's disease. Arch Neurol, 45: 1194-1199.
30. ESMONDE T, GILES E, XUEREB J, HODGES J. (1996). Progressive supranuclear palsy presenting with dynamic aphasia. J Neurol Neurosurg Psychiatry, 60: 403-410.
31. FAYET G, VERCELLETTO M, BERTOUT C, DE KERSAINT-GILLY A, FEVE JR. Anarthrie, apraxie progressive et syndrome extra-pyramidal: forme clinique particulière de dégénérescence corticobasale ? un cas avec étude en tomographie par émission monophotonique au HMPAO Tc99m. Rev Neurol (Paris), 151: 247-250.
32. FEANY MB, MATTIACE LA, DICKSON DW. (1996). Neuropathologic overlap of progressive supranuclear palsy, Pick's disease and corticobasal degeneration. J Neuropathol Exp Neurol, 55: 53-67.
33. FRIEDMAN DI, JANKOVIC J, MCCRARY JA. (1992). Neuro-ophthalmic findings in progressive supranuclear palsy. J Clin Neuroophthalmol, 12: 104-109.
34. GAI WP, POWER JH, BLUMBERGS PC, CULVENOR JG, JENSEN PH. (1999). Alpha-synuclein immunoisolation of glial inclusions from multiple system atrophy brain tissue reveals multiprotein components. J Neurochem, 73: 2093-2100.
35. GIBB WR, LUTHERT PJ, MARSDEN CD. (1989). Corticobasal degeneration. Brain, 112: 1171-1192.
36. GIBB WR, LUTHERT PJ, MARSDEN CD. (1990). Clinical and pathological features of corticobasal degeneration. Adv Neurol, 53: 51-54.
37. GILMAN S, LOW PA, QUINN N, ALBANESE A, BEN-SHLOMO Y, FOWLER CJ, KAUFMANN H, KLOCKGETHER T, LANG AE, LANTOS PL, LITVAN I, MATHIAS CJ, OLIVER E, ROBERTSON D, SCHATZ I, WENNING GK. (1999). Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci, 163: 94-98.
38. GOLBE LI. (1996). The epidemiology of progressive supranuclear palsy. Adv Neurol, 69: 25-31.
39. GOUIDER-KHOUJA N, VIDAILHET M, BONNET AM, PICHON J, AGIOD Y. (1995). Pure striatonigral degeneration and Parkinson's disease. Mov Disord, 3: 288-299.
40. GRAFMAN J, LITVAN I, GOMEZ C, CHASE TN. (1990). Frontal lobe function in progressive supranuclear palsy. Arch Neurol, 47: 553-558.
41. GRAHAM JG, OPPENHEIMER DR. (1969). Orthostatic hypotension and nocotine sensitivity in a case of multiple system atrophy. J Neurol Neurosurg Psychiatry, 32: 28-34.
42. GRANDAS F, ESTEBAN A. (1994). Eyelid motor abnormalities in progressive supranuclear palsy. J Neural Transm, Suppl. 42: 33-41.
43. GRIMES DA, LANG AE, BERGERON CB. (1999). Dementia as the most common presentation of cortical-basal ganglionic degeneration. Neurology, 53: 1969-1974.
44. HUGHES AJ, DANIEL SE, KILFORD L, LEES AJ. (1992). Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry, 55: 181-184.
45. HUGHES AJ, COLOSIMO C, KLEEDORFER B, DANIEL SE, LEES AJ. (1992). The dopaminergic response in multiple system atrophy. J Neurol Neurosurg Psychiatry, 55: 1009-1013.
46. KRAFT E, SCHWARZ J, TRENKWALDER C, VOGL T, PFLUGER T, OERTEL WH. (1999). The combination of hypointense and hyperintense signal changes on T2- weighted magnetic resonance imaging sequences: a specific marker of multiple system atrophy? Arch Neurol, 56: 225-228.
47. KUMAR R, BERGERON C, POLLANEN MS, LANG AE. (1998). Cortical-basal ganglionic degeneration. In: Jankovic J, Tolosa E, (eds). Parkinson's disease and Movement Disorders. 3 ed. pp. 297-316. Willians Wilkins, Baltimore.
48. LANG AE, RILEY DE, BERGERON C. (1994). In: Calne D, (ed). Neurodegenerative Diseases, pp. 877-894. Saunders WB, Philadelphia.
49. LANG AE, BERGERON C, POLLANEN MS, ASHBY P. (1994). Parietal Pick's disease mimicking cortical-basal ganglionic degeneration. Neurology, 44: 1436-1440.
50. LANG AE. (2000). Parkinsonism in corticobasal degeneration. Adv Neurol, 82: 83-89.
51. LEIGUARDA R, LEES AJ, MERELLO M, STARKSTEIN S, MARSDEN CD. (1994). The nature of apraxia in corticobasal degeneration. J Neurol Neurosurg Psychiatry, 57: 455-459.
52. LEIGUARDA RC, PRAMSTALLER PP, MERELLO M, STARKSTEIN S, LEES AJ, MARSDEN CD. (1997). Apraxia in Parkinson's disease, progressive supranuclear palsy, multiple system atrophy and neuroleptic-induced parkinsonism. Brain, 120: 75-90.
53. LÉGER JM, LEVASSEUR M, BENOIT N, BARON JC, TRAN DINH S, BOLGERT F, COHEN L, BRUNET P, SIGNORET JL. (1991). Apraxie d'aggravation lentement progressive: étude par IRM et tomographie à positons dans 4 cas. Rev Neurol (Paris), 147: 183-191.
54. LITVAN I, HAUW JJ, BARTKO JJ, LANTOS PL, DANIEL SE, HOROUPIAN DS, MCKEE A, DICKSON D, BANCHER C, TABATON M, JELLINGER K, ANDERSON D W. (1996). Validity and reliability of the preliminary MINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol, 55: 97-105.
55. LITVAN I, MEGA MS, CUMMINGS JL, FAIRBANKS LA. (1996). Neuropsychiatric aspects of progressive supranuclear palsy. Neurology, 47: 1184-1189.
56. LITVAN I, AGID Y, CALNE D, CAMPBELL G, DUBOIS B, DUVOISIN RC, GOETZ CG, GOLBE LI, GRAFMAN J, GROWDON JH, HALLETT M, JANKOVIC, J, QUINN NP, TOLOSA E, ZEE DS. (1996). Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology, 47: 1-9.
57. LITVAN I, GOETZ CG, JANKOVIC J, WENNING GK, BOOTH V, BARTKO JJ, MCKEE A, JELLINGER K, LAI EC, BRANDEL JP, VERNY M, CHAUDHURI KR, PEARCE RK, AGID Y. (1997). What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic study. Arch Neurol, 54: 937-944.
58. LITVAN I, AGID Y, GOETZ C, JANKOVIC J, WENNING GK, BRANDEL JP, LAI EC, VERNY M, RAY-CHAUDHURI K, McKEE A, JELLINGER K, PEARCE RK, BARTKO JJ. (1997). Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study. Neurology, 48: 119-125.
59. LITVAN I, CAMPBELL G, MANGONE CA, VERNY M, McKEE A, CHAUDHURI KR, JELLINGER K, PEARCE RK, D'OLHABERRIAGUE L. (1997). Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study. Brain, 120: 65-74.
60. LITVAN I, BOOTH V, WENNING GK, BARTKO JJ, GOETZ CG, MCKEE A, JANKOVIC J, JELLINGER K, LAI EC, BRANDEL JP, VERNY M, CHAUDHURI KR, PEARCE RK, AGID Y. (1998). Retrospective application of a set of clinical diagnostic criteria for the diagnosis of multiple system atrophy. J Neural Transm, 105: 217-227.
61. LITVAN I, CUMMINGS JL, MEGA M. (1998). Neuropsychiatric features of corticobasal degeneration. J Neurol Neurosurg Psychiatry, 65: 717-721.
62. LITVAN I, GRIMES DA, LANG AE, JANKOVIC J, MCKEE A, VERNY M, JELLINGER K, CHAUDHURI KR, PEARCE RK. (1999). Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration. J Neurol, 246: S1-S5.
63. LITVAN I, LEES AJ. (1999). Progressive supranuclear palsy. Adv Neurol, 80: 341-345.
64. MALESSA S, HIRSCH EC, CERVERA P, JAVOY-AGID F, DUYCKAERTS C, HAUW JJ, AGID Y. (1991). Progressive supranuclear palsy: loss of choline-acetyltransferase-like immunoreactive neurons in the pontine reticular formation. Neurology, 41: 1593-1597.
65. MATSUO H, TAKASHIMA H, KISHIKAWA M, KINOSHITA I, MORI M, TSUJIHATA M, NAGATAKI S. (1991). Pure akinesia: an atypical manifestation of progressive supranuclear palsy. J Neurol Neurosurg Psychiatry, 54: 397-400.
66. MIZUSAWA H, MOCHIZUKI A, OHKOSHI N, YOSHIZAWA K, KANAZAWA I, IMAI H. (1993). Progressive supranuclear palsy presenting with pure akinesia. Adv Neurol, 60: 618-621.
67. MORRIS HR, LEES AJ, WOOD NW. (1999). Neurofibrillary tangle parkinsonian disorders-tau pathology and tau genetics. Mov Disord, 14: 731-736.
68. PIERROT-DESEILLIGNY C, RIVAUD S, PILLON B, FOURNIER E, AGID Y. (1989). Lateral visually-guided saccades in progressive supranuclear palsy. Brain, 112: 471-487.
69. PIERROT-DESEILLIGNY C, RIVAUD S, GAYMARD B, AGID Y. (1991). Cortical control of visually-guided saccades. Brain, 114: 1473-1485.
70. PHARR V, LITVAN I, BRAT DJ, TRONCOSO J, REICH SG, STARK M. (1999). Ideomotor apraxia in progressive supranuclear palsy: a case study. Mov Disord, 14: 162-166.
71. PILLON B, DEWEER B, MICHON A, MALAPANI C, AGID Y, DUBOIS B. (1994). Are explicit memory disorders of progressive supranuclear palsy related to damage to striatofrontal circuits? Comparison with Alzheimer's, Parkinson's, and Huntington's diseases. Neurology, 44: 1264-1270.
72. PILLON B, GOUIDER-KHOUJA N, DEWEER B, VIDAILHET M, MALAPANI C, DUBOIS B, AGID Y. (1995). Neuropsychological pattern of striatonigral degeneration: comparison with Parkinson's disease and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry, 58: 174-179.
73. PILLON B, BLIN J, VIDAILHET M, DEWEER B, SIRIGU A, DUBOIS B, AGID Y. (1995). The neuropsychological pattern of corticobasal degeneration: comparison with progressive supranuclear palsy and Alzheimer's disease. Neurology, 45: 1477-1483.
74. PILLON B, DUBOIS B, AGID Y. (1996). Testing cognition may contribute to the diagnosis of movement disorders. Neurology, 46: 329-334.
75. PILLON B, DUBOIS B. (2000). Memory and executive processes in corticobasal degeneration. Adv Neurol, 82: 91-101.
76. PRAMSTALLER PP, WENNING GK, SMITH SJ, BECK RO, QUINN NP, FOWLER CJ. (1995). Nerve conduction studies, skeletal muscle EMG, and sphincter EMG in multiple system atrophy. J Neurol Neurosurg Psychiatry, 58: 618-621.
77. QUINN N, WENNING G. (1995). Multiple system atrophy. Curr Opin Neurol, 8: 323-326.
78. QUINN NP, WENNING GK. (1996). Multiple system atrophy. Adv Neurol, 69: 413-419.
79. REBEIZ JJ, KOLODNY EH, RICHARDSON R. (1968). Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol, 18: 20-33.
80. RILEY DE, LANG AE, LEWIS A, ASHBY P, HORNYKIEWICZ O, BLACK S. (1990). Cortico-basal ganglionic degeneration. Neurology 40: 1203-1212.
81. RINNE JO, LEE MS, THOMPSON PD, MARSDEN CD. (1994). Cortico-basal degeneration. A clinical study of 36 cases. Brain, 117: 1183-1196.
82. RIVAUD-PÉCHOUX S, VIDAILHET M, GALLOUEDEC G, LITVAN I, GAYMARD B, PIERROT-DESEILLIGNY C. (2000). Longitudinal ocular motor study in corticobasal degeneration and progressive supranuclear palsy. Neurology in press.
83. RIVEST J, QUINN N, MARSDEN CD. (1990). Dystonia in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Neurology, 40: 1571-1578.
84. ROJO A, PERNAUTE RS, FONTAN A, RUIZ PG, HONNORAT J, LYNCH T, CHIN S, GONZALO I, RABANO A, MARTINEZ A, DANIEL S, PRAMSTELLEH P, MORRIS H, WOOD N, LEES A, TABERNERO C, NYGGARD T, JACKSON AC, HANSON A, DE YEBENES JG. (1999). Clinical genetics of familial progressive supranuclear palsy. Brain, 122: 1233-1245.
85. ROTTACH KG, RILEY DE, DI SCENNA AO, ZIVOTOFSKY AZ, LEIGH RJ. (1996). Dynamic properties of horizontal and vertical eye movements in parkinsonian syndromes. Ann Neurol, 39: 368-377.
86. SAKAKIBARA R, HATTORI T, UCHIYAMA T, ASAHINA M, SUZUKI A, YAMANISHI T, PALACE J, CHANDIRAMANI VA, FOWLER C. (1997). Urinary dysfunction and orthostatic hypotension in multiple system atrophy: which is the more common and earlier manifestation? Value of sphincter electromyography in the diagnosis of multiple system atrophy. Muscle Nerve, 20: 1396-1403.
87. SCHULZ JB, SKALEJ M, WEDEKIND D, LUFT AR, ABELE M, VOIGT K, DICHGANS J, KLOCKGETHER T. (1999). Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy. Ann Neurol, 45: 65-74.
88. SCHRAG A, BEN-SHLOMO Y, QUINN NP. (1999). Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study. Lancet, 354: 1771-1775.
89. SCHWARZ J, KORNHUBER M, BlSCHOFF C, STRAUBE A. (1997). Electromyography of the external anal sphincter in patients with Parkinson's disease and multiple system atrophy: frequency of abnormal spontaneous activity and polyphasic motor unit potentials. Muscle Nerve, 20: 1167-1172.
90. SOLIVERI P, MONZA D, PARIDI D, RADICE D, GRISOLI M, TESTA D, SAVOIARDO M, GIROTTI F. (1999). Cognitive and magnetic resonance imaging aspects of corticobasal degeneration and progressive supranuclear palsy. Neurology, 53: 502-507.
91. STEELE JC, RICHARDSON R, OLSZWESKI J. (1964). Progressive supranuclear palsy. Arch Neurol, 10: 333-359.
92. STOCCHI F, CARBONE A, INGHILLERI M, MONGE A, RUGGIERI S, BERARDELLI A, MANFREDI M. (1997). Urodynamic and neurophysiological evaluation in Parkinson's disease and multiple system atrophy. J Neurol Neurosurg Psychiatry, 62: 507-511.
93. SUYAMA N, KOBAYASHI S, ISINO H, IIJIMA M, IMAOKA K. (1997). Progressive supranuclear palsy with palatal myoclonus. Acta Neuropathol, 94: 290-293.
94. SHY GM, DRAGER GA. (1960). A neurologic syndrome associated with orthostatic hypotension. Arch Neurol, 2: 511-527.
95. TETRUD JW, GOLBE LI, FORNO LS, FARMER PM. (1996). Autopsyproven progressive supranuclear palsy in two siblings. Neurology, 46: 931-934.
96. THOMPSON PD, DAY BL, ROTHWELL JC, BROWN P, BRITTON TC, MARSDEN CD. (1994). The myoclonus in corticobasal degeneration. Evidence for two forms of cortical reflex myoclonus. Brain, 117: 1197-1207.
97. THOMPSON PD. (1995). Myoclonus in corticobasal degeneration. Clin Neurosci, 3: 203-208.
98. THOMPSON PD, SHIBASAKI H. (2000). Myoclonus in corticobasal degeneration and other neurodegenerations. Adv Neurol, 82: 69-81.
99. TISON F, WENNING GK, VOLONTE MA, POEWE WR, HENRY P, QUINN NP. (1996). Pain in multiple system atrophy. J Neurol, 243: 153-156.
100. TISON F. (1997). Other causes of parkinsonism. Baillieres. Clin Neurol, 6: 205-218.
101. VALLDEORIOLA F, VALLS-SOLE J, TOLOSA ES, MARTI MJ. (1995). Striated anal sphincter denervation in patients with progressive supranuclear palsy. Mov Disord, 10: 550-555.
102. VANEK ZF, JANKOVIC J. (2000). Dystonia in corticobasal degeneration. Adv Neurol, 82: 61-67.
103. VIDAILHET M, RIVAUD S, GOUIDER-KHOUJA N, PILLON B, BONNET AM, GAYMARD B, AGID Y, PIERROT-DESEILLIGNY C. (1994). Eye movements in parkinsoni an syndromes. Ann Neurol, 35: 420-426.
104. VIDAILHET M, RIVAUD S, GOUIDER-KHOUJA N, PILLON B, GAYMARD B, AGID Y, KENNARD C, PIERROT-DESEILLIGNY. (1999). Saccades and antisaccades in parkinsonian syndromes. Adv Neurol, 80: 377-382.
105. VIDAILHET M, RIVAUD-PECHOUX S. (2000). Eye movement disorders in corticobasal degeneration. Adv Neurol, 82: 161-167.
106. VERNY M, JELLINGERKA, HAUW JJ, BANCHER C, LITVAN I, AGID Y. (1996). Progressive supranuclear palsy: a clinicopathological study of 21 cases. Acta Neuropathol, 91: 427-431.
107. WENNING GK, BEN SHLOMO Y, MAGALHAES M, DANIEL SE, QUINN NP. (1994). Clinical features and natural history of multiple system atrophy. An analysis of 100 cases. Brain, 117: 835-845.
108. WENNING GK, JAGER R, KENDALL B, KINGSLEY D, DANIEL SE, QUINN NP. (1994). Is cranial computerized tomography useful in the diagnosis of multiple system atrophy? Mov Disord, 9: 333-336.
109. WENNING GK, BEN-SHLOMO Y, MAGALHAES M, DANIEL SE, QUINN NP. (1995). Clinicopathological study of 35 cases of multiple system atrophy. J Neurol Neurosurg Psychiatry, 58: 160-166.
110. WENNING GK, QUINN NP, DANIEL SE, GARRATT H, MARSDEN CD. (1996). Facial dystonia in pathologically proven multiple system atrophy: a video report. Mov Disord, 11: 107-109.
111. WENNING GK, TISON F, BEN SHLOMO Y, DANIEL SE, QUINN NP. (1997). Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord, 12: 133-147.
112. WENNING GK, LITVAN I, JANKOVIC J, GRANATA R, MANGONE CA, McKEE A, POEWE W, JELLINGER K, CHAUDHURI KR, D'OLHABERRIAGUE L, PEARCE RK. (1998). Natural history and survival of 14 patients with corticobasal degeneration confirmed at post-mortem examination. J.Neurol Neurosurg Psychiatry, 64: 184-189.
113. YAGISHITA A, ODA M. (1996). Progressive supranuclear palsy: MRI and pathological findings. Neuroradiology, 38 Suppl 1: S60-6: S60-S66.
114. ZAKZANIS KK, LEACH L, FREEDMAN M. (1998). Structural and functional meta-analytic evidence for fronto-subcortical system deficit in progressive supranuclear palsy. Brain Cogn, 38: 283-296.